GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Registered Plan Private Investments Inc (OTCPK:LXGTF) » Definitions » Short Ratio

Registered Plan Private Investments (Registered Plan Private Investments) Short Ratio


View and export this data going back to 2017. Start your Free Trial

What is Registered Plan Private Investments Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Registered Plan Private Investments (Registered Plan Private Investments) Business Description

Traded in Other Exchanges
N/A
Address
1055 West Hastings Street, Suite 1900, Vancouver, BC, CAN, V6E 2E9
Registered Plan Private Investments Inc is a private investment platform company that allows investors to use their Registered Plans (including registered retirement savings plans, registered education savings plans, tax-free savings accounts, registered retirement income funds, and registered disability savings plans) at their direction to invest in private companies by purchasing tracking shares in RPPI, which in turn uses these proceeds to invest in the specific private company chosen by the investor.

Registered Plan Private Investments (Registered Plan Private Investments) Headlines

From GuruFocus

Lexington Releases Audited Consolidated Financial Statements

By Marketwired Marketwired 05-01-2018

Lexington Biosciences Announces Termination of Private Placement

By Marketwired Marketwired 02-15-2019

Lexington Biosciences Announces Results of Annual General Meeting

By Marketwired Marketwired 07-03-2018

Lexington Provides Q3 Corporate Review

By Marketwired Marketwired 10-24-2018

Lexington Biosciences Provides Update on Financial Situation

By Marketwired Marketwired 04-02-2019

Lexington Announces First Multicenter Clinical Study Site

By Marketwired Marketwired 08-21-2018

Lexington Biosciences Receives HeartSentry USPTO Patent Approval

By Marketwired Marketwired 07-25-2018